AUPR606401A0 - Pyrazolopyridine compound and pharmaceutical use thereof - Google Patents

Pyrazolopyridine compound and pharmaceutical use thereof

Info

Publication number
AUPR606401A0
AUPR606401A0 AUPR6064A AUPR606401A AUPR606401A0 AU PR606401 A0 AUPR606401 A0 AU PR606401A0 AU PR6064 A AUPR6064 A AU PR6064A AU PR606401 A AUPR606401 A AU PR606401A AU PR606401 A0 AUPR606401 A0 AU PR606401A0
Authority
AU
Australia
Prior art keywords
pharmaceutical use
pyrazolopyridine compound
pyrazolopyridine
compound
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR6064A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPR6064A priority Critical patent/AUPR606401A0/en
Publication of AUPR606401A0 publication Critical patent/AUPR606401A0/en
Priority to PCT/JP2002/006671 priority patent/WO2003004494A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPR6064A 2001-07-02 2001-07-02 Pyrazolopyridine compound and pharmaceutical use thereof Abandoned AUPR606401A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AUPR6064A AUPR606401A0 (en) 2001-07-02 2001-07-02 Pyrazolopyridine compound and pharmaceutical use thereof
PCT/JP2002/006671 WO2003004494A1 (en) 2001-07-02 2002-07-02 Pyridazinone compound as adenosine antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR6064A AUPR606401A0 (en) 2001-07-02 2001-07-02 Pyrazolopyridine compound and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
AUPR606401A0 true AUPR606401A0 (en) 2001-07-26

Family

ID=3830028

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR6064A Abandoned AUPR606401A0 (en) 2001-07-02 2001-07-02 Pyrazolopyridine compound and pharmaceutical use thereof

Country Status (2)

Country Link
AU (1) AUPR606401A0 (en)
WO (1) WO2003004494A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120107142A (en) * 2004-01-23 2012-09-28 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 Facially amphiphilic polyaryl and polyarylalkynyl polymers and olygomers and uses thereof
WO2005094885A1 (en) * 2004-03-30 2005-10-13 Kyowa Hakko Kogyo Co., Ltd. Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain
DE102005057924A1 (en) * 2005-12-05 2007-06-06 Merck Patent Gmbh pyridazinone derivatives
DE102007025718A1 (en) * 2007-06-01 2008-12-04 Merck Patent Gmbh pyridazinone derivatives
US10344030B2 (en) * 2014-05-15 2019-07-09 Heesung Material Ltd. Heterocyclic compound and organic light emitting device using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP672198A0 (en) * 1998-10-23 1998-11-19 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
AUPQ441499A0 (en) * 1999-12-02 2000-01-06 Fujisawa Pharmaceutical Co., Ltd. Novel compound

Also Published As

Publication number Publication date
WO2003004494A1 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2002349705A1 (en) Azole compound and medicinal use thereof
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
HUP0302876A3 (en) Pharmaceutical formulation
GB0118689D0 (en) Pharmaceutical formulation
AU2002257582A1 (en) Pharmaceutical formulation
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
PL366432A1 (en) Pharmaceutical formulation
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2002354410A1 (en) Triazole compound and medicinal use thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002251448A1 (en) Oral absorbed drugs
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPP672198A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2002347633A1 (en) Pyrazolopyridine derivtives and their pharmaceutical use
AUPS092602A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
GB0104749D0 (en) Pharmaceutical formulation
AU2002323963A1 (en) Beta-ketoamide compounds and medicinal use thereof